I completely agree and wouldn't rule out the US ei
Post# of 148182
As Dr. Kelly said previously, we are also building up a story of leronlimab each time we talk to these agencies. Next week's meeting with the MHRA, regardless of the fact that it is HIV specific is building the CytoDyn/Leronlimab story in the UK. Safety. Years of Data. Efficacy in more than one trial. I believe that will start to resonate at some point and the dam will burst. All IMO but frustrating that it is taking as long as it is and patients are suffering.